Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomyogenic Hemangioendothelioma.

Ayah Al-Qaderi1, Ahmad T Mansour1

  • 1From the Department of Pathology, Microbiology and Forensic Medicine, School of Medicine-University of Jordan, Jordan University Hospital, Amman, Jordan.

Archives of Pathology & Laboratory Medicine
|December 22, 2018
PubMed
Summary

Pseudomyogenic hemangioendothelioma is a rare vascular tumor affecting young adults, often misdiagnosed. This review details its features and differential diagnosis for better identification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Power of Flow Cytometry in the Cytopathologic Diagnosis of Lymphoid Lesions.

Acta cytologica·2026
Same author

Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers.

bioRxiv : the preprint server for biology·2025
Same author

A Case of Lip Swelling.

The American journal of medicine·2024
Same author

Crystal-storing histiocytosis and associated marginal zone lymphoma with extensive plasmacytic differentiation.

Clinical case reports·2023
Same author

Follicular lymphoma behind a facade of Castleman disease, a diagnostic challenge.

Indian journal of pathology & microbiology·2022
Same author

Pitfalls in Assessing Measurable Residual Disease in Plasma Cell Myeloma: a Comparison between Common Laboratory Tests.

Clinical laboratory·2022

Area of Science:

  • Oncology
  • Pathology
  • Vascular Tumors

Background:

  • Pseudomyogenic hemangioendothelioma (PMH), previously known as epithelioid-sarcoma-like hemangioendothelioma, is a rare vascular tumor.
  • It is characterized by intermediate malignant potential and typically affects young adults, predominantly in the distal lower extremity.
  • PMH presents diagnostic challenges due to a lack of clear morphologic vascular features, necessitating specific immunohistochemical analysis.

Purpose of the Study:

  • To review the clinical, morphologic, and immunohistochemical characteristics of pseudomyogenic hemangioendothelioma.
  • To emphasize the differential diagnosis of PMH, distinguishing it from similar entities like epithelioid sarcoma.
  • To provide an overview of molecular and prognostic features of this rare tumor.

Main Methods:

  • Literature review of clinical, pathological, and molecular data on pseudomyogenic hemangioendothelioma.
  • Analysis of immunohistochemical markers (FLI1, ERG, CD31) crucial for diagnosing PMH.
  • Comparison of PMH with differential diagnoses, including epithelioid sarcoma.

Main Results:

  • PMH exhibits intermediate malignant potential and affects young adults, often in the distal extremities.
  • Immunohistochemistry is essential for confirming vascular differentiation, despite the lack of clear morphologic signs.
  • Diagnostic confusion with other tumors, such as epithelioid sarcoma, is common.

Conclusions:

  • Accurate diagnosis of pseudomyogenic hemangioendothelioma relies on integrating clinical, morphologic, and immunohistochemical findings.
  • Understanding the differential diagnosis is critical for appropriate patient management and treatment.
  • Further research into molecular and prognostic factors will enhance the understanding and treatment of PMH.

Related Experiment Videos